Dasatinib
-
- Applikation
- Inhibition Assay (InhA), Functional Studies (Func)
- Verwendungszweck
- Dasatinib is an oral dual BCR/ABL and Src family tyrosine kinase inhibitor approved for use in patients with chronic myelogenous leukemia (CML). The main targets of Dasatinib, are BCRABL, SRC, Ephrins and GFR.
- Produktmerkmale
-
Tradename: SPRYCEL
Source of Compound: synthetic
Target: Src inhibitor,Abl inhibitor,c-Kit inhibitor,EPHA antagonist
Receptor: Src,Abl, Lck, Yes, Fyn,c-Kit, EPHA 2
- Aufreinigung
- All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
- Reinheit
- 95 %
- Formel
- C22H26ClN7O2S
- Löslichkeit
- DMSO 98 mg/mL,Water <1 mg/mL
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Solid
- Lagerung
- -20 °C
- Informationen zur Lagerung
-
For the majority of compounds, they could be dissolved in DMSO or other organic solvent.
Their stock solution can be stored at -20°C for up to 3 months and aliquoted for sampling convenience.
Several freeze/thaw cycles should not damage the activity of our small molecule products.
However, in many instances the aqueous solutions of some compounds need to be made fresh and cannot be stored. For these compounds, their solution should be prepared just before use and stored no longer than 24 hours. - Haltbarkeit
- 24 months
-
- Hintergrund
- Tyrosine Kinase/Adaptors
- Molekulargewicht
- 488.01 g/mol
- CAS-Nummer
- 302962-49-8
-